Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic acid gel adjunct for peri-implantitis
ACTRN12626000142336Phase 4Not yet recruiting
- Sponsor
- University of Melbourne
- Start
- Apr 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hyaluronic acid in peri-implantitis (2 arms), sponsored by University of Melbourne. Primary endpoints: Change in gingival inflammation around the implant and Change in probing depth at 6 months. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
hyaluronic acid
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on ACTRN12626000142336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000142336.